Dermatica / Skin Glow Treatment
PERSONALISED FORMULA
Two candidate actives — tretinoin 0.025–0.1% and azelaic acid 4–20% — and they are the right two. No hydroquinone, no steroid, nothing with a clock on it. The restraint is real and deliberate. The question is why a prescription consultation is the route to a complaint the page attributes to stress and lack of sleep.
Worth buying for a specific person with a specific problem. Read who.
ASSESSED ON 75% OF THE MODEL. 2 CRITERIA LEFT UNSCORED — SEE SCORING FOR WHY.
Ask which of the two you have been given. If it is azelaic acid, Dermatica sells that over the counter itself at the same strength — no consultation, no subscription.
The verdict
We have now read three Dermatica treatment pages and this is the one that answers the criticism we made of the other two. The melasma pool contains a corticosteroid with an eight-week ceiling and a depigmenting drug with a mandatory break, sold with no duration limit stated. This pool contains tretinoin and azelaic acid, and that is all. Neither has a ceiling, neither needs cycling, and both are drugs a person can reasonably use for years. Dermatica put its duration-limited drugs where the medical need is greatest and kept them entirely out of the elective indication. That is the correct instinct and it deserves saying plainly.
The evidence also holds for what is actually being promised. 'Glow' is unmeasurable as written, but the endpoints underneath it — surface roughness, mottled pigmentation, sallowness, light reflection off a more even stratum corneum — are exactly what the tretinoin photoageing trials record, and they improve earlier than wrinkle depth does. The page says eight weeks. On the anti-ageing page the same company says twelve. Eight weeks for tone and texture is the more defensible of the two claims, and it is the shorter one, which is not the direction marketing copy usually travels.
What we cannot get past is the framing of the front door. The page's own account of why skin looks dull is 'a buildup of dead skin cells, pollution, stress, dehydration or lack of sleep'. Three of those five are states, not pathologies. The route it offers is a medical consultation and a nightly topical retinoid — a drug contraindicated in pregnancy — for a complaint it has just attributed partly to not sleeping enough. Someone treating photoageing with tretinoin has made a considered trade. Someone whose skin looks tired after a hard fortnight may not realise they are making one at all.
And half of what they might be prescribed is not a prescription. Dermatica's own ingredient pages tag adapalene, clindamycin, fluocinolone, hydroquinone, ivermectin, metronidazole and tretinoin as Rx. Azelaic acid is not tagged, and the company sells azelaic acid 15–20% over the counter, itself, at $24.95 a tube. A glow patient who is prescribed azelaic acid has paid a consultation fee and a monthly subscription for something the same shop will sell them without either.
- Two candidate actives, and neither carries a duration limit — the correct pool for an indication that is not a disease.
- Hydroquinone and fluocinolone are deliberately absent, which is exactly the restraint their melasma page lacks.
- Concentrations published on the page: tretinoin 0.025–0.1%, azelaic acid 4–20%.
- The titration policy is stated — start low, increase gradually, and match a previously tolerated tretinoin strength.
- Eight weeks is a realistic timeline for tone and texture, and it is shorter than the twelve weeks the same company claims for wrinkles.
- The only one of Dermatica's three treatment pages to mention sunscreen in visible copy.
- The FAQ gives real non-drug advice — diet, alcohol, smoking, sleep, daily SPF — which argues partly against the need for the product.
- Its retinol explanation is scientifically correct here, unlike the version on the anti-ageing page.
- 'Skin glow' is a preference, not a condition, and the page attributes it partly to stress and lack of sleep before offering a prescription.
- No pregnancy warning, on a page whose pool is half tretinoin. This is the third Dermatica page in a row.
- No side-effect section; the phrase appears once, inside an FAQ about something else.
- Azelaic acid is not Rx by Dermatica's own tagging and is sold over the counter by the same company at 15–20% for $24.95.
- A two-active pool is a thin basis for the word 'personalized'.
- The azelaic range bottoms out at 4%, which is not a treatment dose.
- 'Up to 20x stronger than the high street' again, with no comparator named on the page.
- 'FDA REGULATED' again, in a badge strip beside '100% VEGAN', on a compounded product.
- A featured testimonial reports tretinoin strengths as '0.25' and '0.5' — tenfold overstatements — on the page whose FAQ explains why tretinoin percentages look low.
- No fill size and no INCI for the base, so neither cost per application nor the vehicle is knowable.
Every active, assessed
- Tretinoin0.025%–0.1%
Retinoid — increases turnover, disperses pigment, smooths the stratum corneum
- BENCHMARK
- 0.025%–0.1% is the trial range for photoageing
- ASSESSMENT
- The right drug for this and the published range is exactly the therapeutic band. Tretinoin improves roughness, sallowness and mottled pigmentation earlier in a course than it improves wrinkles, which is precisely what 'glow' describes. The eight-week claim follows honestly from that. It is also a teratogen-class topical, and that is the half of the story this page does not tell.
- Azelaic Acid4%–20%
Tyrosinase inhibitor, antioxidant, normalises keratinisation
- BENCHMARK
- 15%–20% is the treatment range; below that it is supporting
- ASSESSMENT
- Well chosen and, at the top of the range, genuinely effective on tone evenness. Two caveats. The floor of 4% is not a treatment dose, and a five-fold range means two people on 'azelaic acid' hold different products. And Dermatica does not tag it Rx anywhere on its site, while selling it over the counter at 15–20% — so for half this pool the prescription gate is not doing any gating.
| ACTIVE | CONC. | BENCHMARK | ASSESSMENT |
|---|---|---|---|
| TretinoinRetinoid — increases turnover, disperses pigment, smooths the stratum corneum | 0.025%–0.1% | 0.025%–0.1% is the trial range for photoageing | The right drug for this and the published range is exactly the therapeutic band. Tretinoin improves roughness, sallowness and mottled pigmentation earlier in a course than it improves wrinkles, which is precisely what 'glow' describes. The eight-week claim follows honestly from that. It is also a teratogen-class topical, and that is the half of the story this page does not tell. |
| Azelaic AcidTyrosinase inhibitor, antioxidant, normalises keratinisation | 4%–20% | 15%–20% is the treatment range; below that it is supporting | Well chosen and, at the top of the range, genuinely effective on tone evenness. Two caveats. The floor of 4% is not a treatment dose, and a five-fold range means two people on 'azelaic acid' hold different products. And Dermatica does not tag it Rx anywhere on its site, while selling it over the counter at 15–20% — so for half this pool the prescription gate is not doing any gating. |
Scoring
- EVIDENCE FOR THE ACTIVEWEIGHT 30%80/100
Tretinoin's evidence for roughness, sallowness and mottled pigmentation is strong and directly matches what this page promises, at a published range that is correct throughout, on a timeline that is honest. Azelaic acid at the top of its range is well evidenced for tone. Below the other two Dermatica pages because the indication has no measurable endpoint, because the floor of the azelaic range is not a working dose, and because a two-candidate pool leaves little to personalise.
- FORMULATION INTEGRITYWEIGHT 20%72/100
The best pool design we have seen from this company. Both duration-limited drugs — hydroquinone and fluocinolone — are excluded from the elective indication, leaving two actives that can be used indefinitely without a stop date. The titration policy is stated on the page: start low, increase gradually, match a prior tretinoin strength if you had one. Marked down for the same unpublished SmartBase INCI as its siblings, and because two candidates is a thin basis for a personalised formula.
- DISCLOSUREWEIGHT 15%56/100
The best of the three Dermatica pages and still short. Concentrations published, a stated titration policy, the only one of the three to mention sunscreen in visible copy, and an FAQ that gives genuine non-drug advice. Against: no pregnancy warning on a page whose pool is half tretinoin, effectively no side-effect content, no INCI, no fill size, the unanchored 20x claim, the FDA badge, and a featured testimonial that misstates tretinoin strengths tenfold on the very page explaining them.
- TOLERANCE IN USEWEIGHT 15%NOT ASSESSED
Not assessed. Tolerance decides this one more than most, because a person treating dullness rather than disease has the least reason to push through retinisation — and retinisation looks exactly like the dullness they came to fix.
- TEXTURE & WEARWEIGHT 10%NOT ASSESSED
Not assessed. Requires the product in hand across the full adjustment window.
- COST PER APPLICATIONWEIGHT 10%58/100
$29.95 a month with prescriber and adjustments included is fair for supervised tretinoin, and cheaper than any in-person route. It is poor value in the other branch of the pool: azelaic acid is not Rx by Dermatica's own tagging and the company sells it over the counter at 15–20% for $24.95. No fill size is published, so cost per application remains incomputable across all three of their pages.
What it is
A compounded prescription night cream aimed at dullness, prescribed after an online consultation, at $29.95 a month following a $4.99 first month. The published candidate pool is two actives — tretinoin 0.025–0.1% and azelaic acid 4–20% — blended into the company's SmartBase. Two bottles ship every 56 days.
The pool is two drugs, and they are the right two
We were hard on the melasma page for selling a corticosteroid with no stated stop, and on the anti-ageing page for putting hydroquinone on a twelve-month prepay. It is only fair to be equally direct when the same company gets the same decision right, and here it does.
Counted from the three treatment pages as published, 27 July 2026. The two actives that carry duration limits — hydroquinone and fluocinolone acetonide — appear where the medical need is greatest and are absent from the elective indication entirely. That is the correct instinct, and it is the strongest thing in this review.
This matters more than a two-item list suggests. The structural complaint this register has made across twenty-one reviews is that drugs requiring a stop are sold through subscriptions that never stop. The cleanest solution is not a better cycling protocol — it is not putting a drug that needs cycling into a product that will not cycle. On this page, Dermatica has done exactly that.
It also means the open-ended subscription, which we criticised on both sibling pages, is defensible here. Tretinoin is a maintenance drug. Using it nightly for years is the normal way to use it, not a failure to stop.
But 'skin glow' is not a condition
Every other page in this register treats something: acne, melasma, hyperpigmentation, keratosis pilaris, photoageing. Those are diagnoses. This page treats dullness, and here is its own explanation of where dullness comes from:
Skin can appear tired or grey due to a buildup of dead skin cells, pollution, stress, dehydration or lack of sleep.
Dermatica, skin glow treatment page
One of those five is a skin finding. Two are environmental. Two are how your week went. And the response offered is a medical consultation, a prescriber, and a nightly topical retinoid contraindicated in pregnancy.
We have consistently credited these companies for putting real drugs behind a prescriber rather than selling them as cosmetics. That gate exists so somebody weighs benefit against risk. When the benefit side is a diagnosis, the weighing is straightforward. When it is 'my skin looks tired', the drug's risks have not moved an inch but the benefit being weighed against them has become a preference. Nothing on this page is false. What it does is lower the threshold at which a person decides a prescription is the answer.
The honest counter-argument, which we accept as far as it goes: dullness at thirty-five very often is early photoageing, and tretinoin is the correct treatment for that. Many people arriving at this page are the same people who should be on the anti-ageing page, and they will get a good drug at a correct dose either way. The objection is not that the treatment is wrong for them. It is that the door is wide enough to admit people for whom the answer was sleep.
To Dermatica's credit, its own FAQ makes that argument better than we can. Asked what else helps, the page recommends a gentle cleanser, moisturiser and sunscreen, a balanced diet, exercise, less alcohol, no smoking, and regular SPF. That is a genuinely good answer, it is most of what dullness actually needs, and none of it requires a prescriber. A page that argues partly against its own necessity is doing something rare, and we are not going to pretend otherwise.
Half the pool is not a prescription at all
Dermatica marks its prescription actives with an Rx tag. Across the ingredient library that tag sits on adapalene, clindamycin, fluocinolone acetonide, hydroquinone, ivermectin, metronidazole and tretinoin. It does not sit on azelaic acid, benzoyl peroxide, niacinamide or tranexamic acid.
On this page, tretinoin carries the Rx tag and azelaic acid does not. And Dermatica sells azelaic acid over the counter itself — the Clarifying Azelaic Acid 15–20% Cream, $24.95 for 1 fl.oz, no consultation, full ingredient list, published fill size.
So a person who completes a consultation for glow and is prescribed azelaic acid has paid a $4.99 prescribing fee and entered a $29.95 monthly subscription to receive, in an undisclosed base at an undisclosed fill size, an ingredient the same company sells them across the aisle at a higher published strength with the INCI printed on it. With a two-candidate pool, that is roughly a coin toss.
Say on the page which of the two you are likely to receive and why, and tell azelaic-acid candidates that the over-the-counter cream exists. Dermatica already does this kind of cross-referencing well — the retinal serum page points pregnant readers at pregnancy-safe alternatives by name. The same sentence here would cost one sale and buy a great deal of trust.
Third page, third missing pregnancy warning
We have now searched three Dermatica treatment pages for a pregnancy contra-indication and found none on any of them. The anti-ageing page: zero mentions. The melasma page: three mentions, all describing pregnancy as a cause of the condition. This page: zero.
One page is an oversight. Three is the template. And the copy exists — it is on the tretinoin ingredient page, correctly worded, and in a fuller and better form on a $39.99 cosmetic serum that names pregnancy-safe alternatives and mentions that a pregnancy-safe personalised formula exists.
The argument for it being worst here is that this indication is the most elective of the three. A person treating melasma or photoageing has a problem and is trading against it. A person who wants to look less tired is making a lifestyle purchase, and lifestyle purchases are exactly the ones people make without reading much. That is the reader who most needs the warning at the point of decision, and this is the page that gives them the least.
Two places this page is better than its siblings
First, sunscreen. Of Dermatica's three treatment pages this is the only one with the word in its visible copy, and the FAQ goes further: 'we strongly advise applying SPF regularly and taking precaution to avoid direct sunlight.' On the anti-ageing page, selling the same photosensitising retinoid, the visible count is zero.
Second, the retinol explanation. The anti-ageing page answers the tretinoin-versus-retinol question with a category error — it says retinol is 'weaker in strength than a retinoid', when retinol is itself a retinoid. This page answers the same question correctly: over-the-counter retinols are sold at higher percentages but are inactive vitamin A derivatives that must be converted in the skin, whereas prescription retinoids arrive already active, so a lower number is not a weaker product.
That second one is the single most useful paragraph on any Dermatica page, because it defuses the thing that makes people ask for a stronger formula than they need. It belongs on all three pages, and the wrong version should come down.
One small irony in the testimonials
Directly above the FAQ explaining why prescription tretinoin percentages look low sits a featured customer review: 'It started on a lower % of 0.25 & is now 0.5.' Those are almost certainly 0.025% and 0.05% — the bottom two rungs of the published range — reported ten times too high.
It is a customer's slip, not the company's, and it appears on all three treatment pages because the testimonial block is shared. But a page whose central educational point is that tretinoin numbers are small and that this is fine, running a hand-picked review that inflates those numbers tenfold, is worth a moment. Pick a different quote.
If you are considering it
- Decide whether your complaint is dullness or photoageing. If it is photoageing, you want the same drug and should read the anti-ageing review too.
- If it is genuinely tiredness, dehydration or sleep, read this page's own FAQ and do that first. It is free and it is the correct answer.
- Ask which of the two actives you have been prescribed, and at what strength.
- If it is azelaic acid, ask why the over-the-counter 15–20% cream is not the better buy. It may well be.
- If you are pregnant, breastfeeding or trying to conceive, say so unprompted. Half this pool is a retinoid and nothing on the page will ask you.
- Wear daily SPF. This page does tell you to, which is more than its siblings manage.
- Give it eight to twelve weeks and expect the first few to look worse, not better. Retinisation and dullness look alike.
Where we stand
At 70 this sits between its two siblings — a point below the anti-ageing page, a point above melasma — and all three land within two points of each other, which is itself the finding. Dermatica is consistent. The composition disclosure is the best in this register on all three pages, the risk disclosure is absent on all three, and the differences between indications matter less than the difference between this company and everyone else.
What lifts this page is a decision nobody had to make. Having built a palette containing a corticosteroid and a depigmenting agent, Dermatica could easily have offered them here — brightening sells, and hydroquinone would have made the glow claim land faster. It kept them out and shipped the two drugs that can be taken indefinitely without harm. That is the clearest evidence in four reviews that there are people at this company thinking about duration, even though none of their pages says a word about it.
What holds it down is the door. Add the pregnancy warning that is already written elsewhere on the site. Tell azelaic-acid patients that the same ingredient is on the shelf without a subscription. And say somewhere on the page that if the honest answer is sleep, water and sunscreen, that is a good answer and it is free — which the FAQ almost says already. Do those three and this becomes a genuinely well-made product with an honestly drawn front door.
Who this is for
- Someone who has decided they want prescription tretinoin for texture and tone, and understands that is what they are buying rather than a glow treatment.
- Someone stepping up from an over-the-counter retinol who wants supervision and a stated titration path.
- Someone who would rather have the two drugs without a clock than the five with two clocks on the melasma page.
- Someone who will wear daily SPF — which this page, alone of the three, does at least mention.
- Someone who will give it eight to twelve weeks and judge it on evenness and texture rather than on a word.
- You are pregnant, breastfeeding or trying to conceive. Half this pool is tretinoin and the page will not warn you — ask for the pregnancy-safe formula, which the company runs.
- Your complaint is genuinely tiredness, dehydration or a bad month's sleep. The page's own FAQ tells you what to do about those and none of it requires a prescription.
- You would be prescribed azelaic acid and would rather not pay a subscription for something sold over the counter downstairs.
- You are already using a retinoid. Do not stack them.
- You have active eczema, rosacea or a compromised barrier — retinisation will look worse than the dullness did.
Ask which of the two you have been given. If it is azelaic acid, Dermatica sells that over the counter itself at the same strength — no consultation, no subscription.
This is an editorial assessment of published information about a prescription product. It is not a diagnosis, not a prescription and not a substitute for your own prescriber. Hydroquinone and tretinoin are drugs. Decisions about them belong with a clinician who has seen your skin.
Sources
- S-01Dermatica — skin glow treatment page The two-active pool with concentrations, the Rx tag on tretinoin and its absence on azelaic acid, the eight-week claim, the dullness aetiology, the titration and retinol FAQs, the sunscreen and lifestyle advice, and the absence of any pregnancy or side-effect content. Read 27 July 2026.
- S-02Dermatica — ingredients index The Rx tagging across the palette: adapalene, clindamycin, fluocinolone, hydroquinone, ivermectin, metronidazole and tretinoin marked Rx; azelaic acid, benzoyl peroxide, niacinamide and tranexamic acid not.
- S-03Dermatica — Clarifying Azelaic Acid 15–20% Cream The same ingredient sold over the counter by the same company at a higher published strength, $24.95 for 1 fl.oz, with full INCI and a stated fill size.
- S-04Dermatica — anti-ageing treatment page The twelve-week claim and the retinol-versus-retinoid FAQ containing the category error this page corrects, used for the cross-page comparison.
- S-05Dermatica — melasma treatment page The five-active pool including hydroquinone 4% and fluocinolone acetonide 0.01%, used as the comparison in Fig. 1.
- S-06Dermatica — tretinoin ingredient page Where the pregnancy and contraception warning actually lives, along with the side-effect list and sunscreen instruction absent from this treatment page.